Research Scholar
CohereFull Time
Internship
Every Cure is an AI-driven nonprofit, biotech organization on a mission to save and improve lives by repurposing existing medicines for diseases with significant unmet need. Our vision is a world where no patients suffer when there’s a treatment sitting at their local pharmacy that could be repurposed to treat them. We are filling a gap left by the current biomedical system, which doesn’t pursue new uses for cheap, old drugs. Through artificial intelligence technologies, collaboration with healthcare professionals, and patient advocacy, Every Cure is dedicated to unlocking the full potential of existing medicines to treat every disease and every patient we possibly can. Inspired by Every Cure’s co-founders' work repurposing drugs for Castleman disease and other rare diseases, Every Cure is advancing repurposed treatments for neglected diseases and has been featured in New York Times, USA Today, and Good Morning America. Led by a talented leadership team and an outstanding Board of Directors, Every Cure is supported through funding from leading philanthropic organizations like Chan Zuckerberg Initiative and Elevate Prize Foundation and a federal contract with ARPA-H.
Every Cure is seeking a mission-driven Research Fellow (industry Scientist-Scientist II equivalent) to evaluate, nominate, and advance high-potential drug repurposing opportunities. Reporting to the Vice President of Discovery, this role is critical to shaping our evidence-based strategy by rigorously assessing therapeutic potential, feasibility, and impact. The Research Fellow will work cross-functionally with disease experts, internal teams, and our Scientific Advisory Committee to bridge knowledge gaps and drive forward research plans encompassing lab experiments, real-world data analysis, clinical trials, and public dissemination efforts. While disease-area expertise is welcome, this individual must be a generalist by nature with a deep interest in better understanding a wide range of disease-relevant biology.
Produces animal-free protein using fermentation
The EVERY Company produces animal-free protein, focusing on vegan egg protein ingredients made through precision fermentation. This process merges traditional fermentation with modern technology to create sustainable protein without animal farming. The company primarily serves food and beverage brands that want to offer ethical and sustainable products, targeting health-conscious consumers, vegans, and environmentally aware individuals. EVERY operates on a B2B model, partnering with large distributors like Ingredion and AB InBev BioBrew to expand its reach. Revenue comes from selling its protein ingredients to manufacturers, who then create their own plant-based products. The goal of The EVERY Company is to lead the animal-free protein movement by providing high-quality, sustainable ingredients that meet the growing demand for plant-based alternatives.